On November 27, 2019 IMV Inc. ("IMV" or the "Corporation") (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, reported that the IMV’s executive management team will participate in two upcoming investor conferences in December (Press release, IMV, NOV 27, 2019, View Source [SID1234551748]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray 31st Annual Healthcare Conference
Date: Wednesday, December 4, 2019
Presentation Time: 8:50 a.m. Eastern Time
Location: New York, NY

LD Micro 12th Annual Main Event
Date: Wednesday, December 11, 2019
Presentation Time: 4:20 p.m. Eastern Time (1:20 p.m. Pacific Time)
Location: Los Angeles, CA

A live webcast of these presentations will be available under "Events, Webcasts and Presentations" in the investors section of IMV’s website and a replay will be available approximately one hour after the presentation. Afterwards, it will be available for approximately 30 days.